Optimas Capital’s MetLife MET Stock Holding History

Optimas Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-46,100	Closed	-$2.9M	–	48
2023 Q3	$2.9M	Buy	+46,100	New	+$2.87M	1.99%	15

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Optimas Capital's MET Position: Q4 2023 in Review

Optimas Capital sold out of MetLife (MET) in Q4 2023, closing a stake of 46,100 shares — an estimated $2.9M sold.

Optimas Capital first reported a position in MET in Q3 2023 and held it in 1 quarter. The position peaked at $2.9M in Q3 2023. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

Optimas Capital reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
Optimas Capital sold 46,100 MetLife shares in Q4 2023, an estimated $2.9M.
Optimas Capital first reported a position in MetLife in Q3 2023 and held it in 1 quarter.
Optimas Capital's MetLife position peaked at $2.9M in Q3 2023.
1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on Optimas Capital's 13F filing for Q4 2023, filed 23 Jan 2024.